BREATHE LIFE SCIENCES UK LTDActive
Key figures
Like most small UK companies, BREATHE LIFE SCIENCES UK LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2022/23–2024/25
| 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|
| Cash at bank and in hand | 82,171 | 21,229 | 4,100 |
| Total assets | 544,427 | 176,846 | 234,250 |
| Total liabilities | 966,055 | 561,368 | 704,060 |
| Net assets / total equity | -412,445 | -376,500 | -465,799 |
| Average number of employees | 11 | 9 | 6 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Breathe Life Sciences UK Limited is a private company limited by shares, incorporated in England and Wales. The registered number is 14009276. The company is the manufacturer and wholesaler of wellness oils, cosmetics and nootropic capsules.
As described in the company's latest filed accounts.
Summary: BREATHE LIFE SCIENCES UK LTD
Company
BREATHE LIFE SCIENCES UK LTD is a private limited company registered with Companies House under company number 14009276. It was incorporated on 29 Mar 2022. Its status is active. The registered office is in London (W10). Its nature of business (SIC 2007) is non-specialised wholesale trade (46900).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files abridged accounts (unaudited). Net assets were −£465,799, down 23.7% on the previous year. Cash at bank and in hand was £4,100. Total assets were £234,250 and total liabilities £704,060. The company had an average of 6 employees. Figures are available for 3 financial years (2022/23–2024/25).
Control and charges
One person with significant control is registered. 2 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 11 Apr 2027.